Cargando…

Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety

Randomized controlled trials (RCTs) have shown an antidepressant effect of glabellar botulinum toxin (BoNT) injections. In the FDA Adverse Event Reporting System (FAERS) database, BoNT injection is associated with reduced incidence rates of depression across various non-psychiatric indications, whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wollmer, M. Axel, Makunts, Tigran, Krüger, Tillmann H. C., Abagyan, Ruben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692576/ https://www.ncbi.nlm.nih.gov/pubmed/34934096 http://dx.doi.org/10.1038/s41598-021-03713-x

Ejemplares similares

Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
por: Makunts, Tigran, et al.
Publicado: (2020)

Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
por: Joulfayan, Haroutyun, et al.
Publicado: (2023)

Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis
por: Makunts, Tigran, et al.
Publicado: (2019)

Treatment of Depression with Botulinum Toxin
por: Wollmer, Marc Axel, et al.
Publicado: (2022)

Common osteoporosis drug associated with increased rates of depression and anxiety
por: Keshishi, Dro, et al.
Publicado: (2021)

Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
por: Cohen, Isaac V., et al.
Publicado: (2021)

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
por: Cohen, Isaac V., et al.
Publicado: (2020)

How can proton pump inhibitors damage central and peripheral nervous systems?
por: Makunts, Tigran, et al.
Publicado: (2020)

Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study
por: Lehnert, Franziska, et al.
Publicado: (2023)

Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events
por: Makunts, Tigran, et al.
Publicado: (2022)

Agitation Predicts Response of Depression to Botulinum Toxin Treatment in a Randomized Controlled Trial
por: Wollmer, M. Axel, et al.
Publicado: (2014)

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids
por: Makunts, Tigran, et al.
Publicado: (2019)

Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Cohen, Isaac V., et al.
Publicado: (2017)

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Cohen, Isaac V., et al.
Publicado: (2017)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
por: Makunts, Tigran, et al.
Publicado: (2022)

Postmarketing Safety Surveillance and Reevaluation of Danhong Injection: Clinical Study of 30888 Cases
por: Li, Xue-Lin, et al.
Publicado: (2015)

Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain
por: Makunts, Tigran, et al.
Publicado: (2018)

Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder
por: Kruger, Tillmann H. C., et al.
Publicado: (2022)

Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
por: Makunts, Tigran, et al.
Publicado: (2019)

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system
por: Makunts, Tigran, et al.
Publicado: (2023)

Long-Term Efficacy and Safety of Botulinum Toxin Injections in Dystonia
por: Ramirez-Castaneda, Juan, et al.
Publicado: (2013)

Postmarketing Safety Study Tool: A Web Based, Dynamic, and Interoperable System for Postmarketing Drug Surveillance Studies
por: Sinaci, A. Anil, et al.
Publicado: (2015)

Postmarketing Surveillance Study of the Efficacy and Safety of Phentermine in Patients with Obesity
por: Kim, Hyun Ok, et al.
Publicado: (2013)

Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan†
por: Kurita, Tomoko, et al.
Publicado: (2014)

An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance
por: Misu, Takashi, et al.
Publicado: (2018)

Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
por: Garafola, Svetlana, et al.
Publicado: (2023)

Injecting botulinum toxin into the treatment of blepharospasm
por: Popescu, Marius Nicolae, et al.
Publicado: (2018)

Safety and efficacy of botulinum toxin injection therapy for esophageal achalasia in Japan
por: Yamaguchi, Daisuke, et al.
Publicado: (2015)

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
por: Koike, Takao, et al.
Publicado: (2011)

Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis
por: Harigai, Masayoshi, et al.
Publicado: (2016)

Safety of Gliadel Implant for Malignant Glioma: Report of Postmarketing Surveillance in Japan
por: NISHIKAWA, Ryo, et al.
Publicado: (2021)

Efficacy and safety of botulinum toxin a injection into urethral sphincter for underactive bladder
por: Chen, Guoqing, et al.
Publicado: (2019)

Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection
por: Mueller, Joerg, et al.
Publicado: (2022)

Treatment of Palatal Myoclonus with Botulinum Toxin Injection
por: Anis, Mursalin M., et al.
Publicado: (2013)

Efficacy of Botulinum Toxin Injection in Exotropia Treatment
por: Al Hemaidi, Seham S., et al.
Publicado: (2021)

Effectiveness of drug postmarketing all-case surveillance as a safety measure in Japan
por: Kondo, Hideyuki, et al.
Publicado: (2021)

Safety of oral nemonoxacin: A systematic review of clinical trials and postmarketing surveillance
por: Yuan, Jinyi, et al.
Publicado: (2022)

The Importance of Registries in the Postmarketing Surveillance of Surgical Meshes
por: Köckerling, Ferdinand, et al.
Publicado: (2018)

Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use
por: Crawford, Melissa, et al.
Publicado: (2020)

EU postmarket surveillance plans for medical devices
por: Pane, Josep, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6vv9655p0mgo1ralorvnmi740i